• 1
    Hardy, R. R., B-1 B cell development. J. Immunol. 2006. 177: 27492754.
  • 2
    Berland, R. and Wortis, H. H., Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 2002. 20: 253300.
  • 3
    Rothstein, T. L., Cutting edge commentary: two B-1 or not to be one. J. Immunol. 2002. 168: 42574261.
  • 4
    Briles, D. E., Nahm, M., Schroer, K., Davie, J., Baker, P., Kearney, J. and Barletta, R., Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 1981. 153: 694705.
  • 5
    Boes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C. and Chen, J., A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 1998. 188: 23812386.
  • 6
    Ochsenbein, A. F., Fehr, T., Lutz, C., Suter, M., Brombacher, F., Hengartner, H. and Zinkernagel, R. M., Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999. 286: 21562159.
  • 7
    Baumgarth, N., Herman, O. C., Jager, G. C., Brown, L. E., Herzenberg, L. A. and Chen, J., B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 2000. 192: 271280.
  • 8
    Haas, K. M., Poe, J. C., Steeber, D. A. and Tedder, T. F., B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005. 23: 718.
  • 9
    Carmack, C. E., Shinton, S. A., Hayakawa, K. and Hardy, R. R., Rearrangement and selection of VH11 in the Ly-1 B cell lineage. J. Exp. Med. 1990. 172: 371374.
  • 10
    Mercolino, T. J., Arnold, L. W., Hawkins, L. A. and Haughton, G., Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J. Exp. Med. 1988. 168: 687698.
  • 11
    Wang, H. and Clarke, S. H., Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol. Rev. 2004. 197: 5159.
  • 12
    Mercolino, T. J., Arnold, L. W. and Haughton, G., Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J. Exp. Med. 1986. 163: 155165.
  • 13
    Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T. and Honjo, T., PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 2001. 98: 1386613871.
  • 14
    Zhong, X., Bai, C., Gao, W., Strom, T. B. and Rothstein, T. L., Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger. Int. Immunol. 2004. 16: 11811188.
  • 15
    Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S. et al., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001. 291: 319322.
  • 16
    Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M. et al., Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 2003. 9: 14771483.
  • 17
    Sharpe, A. H., Wherry, E. J., Ahmed, R. and Freeman, G. J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007. 8: 239245.
  • 18
    Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y. et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261268.
  • 19
    Loke, P. and Allison, J. P., PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. USA 2003. 100: 53365341.
  • 20
    Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J. and Sharpe, A. H., Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 2003. 33: 27062716.
  • 21
    Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T. et al., Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 2002. 169: 55385545.
  • 22
    Rothstein, T. L. and Kolber, D. L., Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J. Immunol. 1988. 140: 28802885.
  • 23
    Fischer, G. M., Solt, L. A., Hastings, W. D., Yang, K., Gerstein, R. M., Nikolajczyk, B. S., Clarke, S. H. and Rothstein, T. L., Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. Cell. Immunol. 2001. 213: 6271.
  • 24
    Tumang, J. R., Frances, R., Yeo, S. G. and Rothstein, T. L., Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J. Immunol. 2005. 174: 31733177.
  • 25
    Youngnak, P., Kozono, Y., Kozono, H., Iwai, H., Otsuki, N., Jin, H., Omura, K. et al., Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem. Biophys. Res. Commun. 2003. 307: 672677.
  • 26
    Murphy, T. P., Kolber, D. L. and Rothstein, T. L., Elevated expression of Pgp-1 (Ly-24) by murine peritoneal B lymphocytes. Eur. J. Immunol. 1990. 20: 11371142.
  • 27
    Montecino-Rodriguez, E., Leathers, H. and Dorshkind, K., Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 2006. 7: 293301.
  • 28
    Radhakrishnan, S., Nguyen, L. T., Ciric, B., Van Keulen, V. P. and Pease, L. R., B7-DC/PD-L2 cross-linking induces NF-{kappa}B-dependent protection of dendritic cells from cell death. J. Immunol. 2007. 178: 14261432.